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patients and 128 bypass grafts in 119 patients were enrolled in the study. All patients had rest pain and/or tissue loss. Primary endpoints were survival free from amputation and sustained clinical improvement. Secondary endpoints were major adverse events (MAE), the binary restenosis rate, freedom from TLR, and a special quality-adjusted life year (QALY) endpoint (Q-TWiST) that incorporated both length and quality of life to evaluate treatments Results: At 5 years, clinical improvement was sustained in 82.8% of the SIA group versus 68.2% of the BG patients (p50.106). Five-year all-cause survival was similar for SIA (78.6%) and BG (80.1%; p=0.734), as was amputation-free survival (SIA 72.9% versus BG 71.2%; p=0.976) . Hyperfibrinogenemia (p=0.009) and C-reactive protein (p=0.019) had negative effects on survival without amputation. Five-year freedom from binary restenosis rates were 72.8% for SIA versus 65.3% for BG (p=0.700). While the 5-year freedom from TLR rates (SIA 85.9% versus BS 72.1%, p=0.262) were not statistically significant, the risk of MAE (p<0.002) and length of hospital stay (p<0.0001) were significantly reduced. Q-TWiST significantly improved (p<0.001) and cost-per-QALY was reduced with SIA. The 5-year risk of re-intervention (p>0.05) and mean number of procedures (p=0.078) were similar. Conclusion: Five-year freedom from MAE was enhanced by 20% in the SIA group, with substantial cost reduction and better Q-TWiST. SIA is a minimally invasive technique that expands amputation-free and symptom-free survival. SIA is a paradigm shift in the management of CLI. Background: The severity of residual stenosis (RS) in central vein stenosis(CVS) sometimes hard to be accurately measured by angiographic image. Because of intracoronary pressure is good alternative parameter in coronary intervention, the role of pull-back pressure measurement in percutaneous transluminal angioplasty for CVS was evaluated. Methods: This study retrospectively reviewed consecutive 94 dialysis patients asked for management of CVS which were divided into two groups by aniographic image or post-intervention pressure gradient (PG), and followed up long term clinical outcomes. 12-month patency rate between groups were compared and analyzed. Results: The 94 patients consisted of 47 males and 47 females. There were divided into two groups which included 63 cases in successful group (RS<30%) and 31 cases in acceptable group (50%>RS>30% ) by aniographic criteria, or which included 51 cases in PG<5 mmHg(PG1 group) and 43 cases in PG>5mmHg(PG2 group) by measured pullback PG. the baseline characteristics and parameters during intervention between groups were almost no statistical difference. 12-month patency rate in successful group vs. acceptable group were 54% vs. 39%( P= 0.167), while in PG1 group and PG2 group were 60% vs 37% ( P= 0.048). Further, subgroup analysis between PG1 group vs. group accordance to the criteria of accepted group plus PG2 group were 60% vs 29%(P=0.058).
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